NVRO Stock Recent News

NVRO LATEST HEADLINES

NVRO Stock News Image - Zacks Investment Research

Nevro's (NVRO) worldwide revenues improve on a year-over-year basis in the second quarter owing to robust domestic and international performances.

Zacks Investment Research 2023 Aug 02
NVRO Stock News Image - Seeking Alpha

Nevro Corp. (NYSE:NVRO ) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Greg Chodaczek - Gilmartin Group LLC Kevin Thornal - President and CEO Rod MacLeod - Chief Financial Officer Conference Call Participants Anthony Petrone - Mizuho Group Simran Kaur - Piper Sandler Nathan Treybeck - Wells Fargo Allen Gong - JPMorgan Brandon Vazquez - William Blair Brad Bowers - Mizuho Securities David Turkaly - JMP Securities Operator Ladies and gentlemen, good afternoon. My name is Abby, and I will be your conference operator today.

Seeking Alpha 2023 Aug 01
NVRO Stock News Image - Zacks Investment Research

Nevro (NVRO) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of $0.68. This compares to loss of $0.71 per share a year ago.

Zacks Investment Research 2023 Aug 01
NVRO Stock News Image - Zacks Investment Research

Investors continue to be optimistic about Nevro (NVRO) due to its R&D edge.

Zacks Investment Research 2023 Jun 19
NVRO Stock News Image - Seeking Alpha

Nevro is a company dedicated to the design and manufacture of medical devices. I believe that further news about the efficacy of the product, sufficient marketing, and internationalization efforts could bring significant FCF growth and stock price appreciation.

Seeking Alpha 2023 May 09
NVRO Stock News Image - Zacks Investment Research

Nevro's (NVRO) worldwide revenues improve on a year-over-year basis in Q1, partly owing to robust domestic performance.

Zacks Investment Research 2023 Apr 27
NVRO Stock News Image - Seeking Alpha

Nevro Corp. (NVRO) Q1 2023 Earnings Call Transcript.

Seeking Alpha 2023 Apr 26
NVRO Stock News Image - Zacks Investment Research

Nevro (NVRO) came out with a quarterly loss of $0.98 per share versus the Zacks Consensus Estimate of a loss of $1.06. This compares to loss of $0.98 per share a year ago.

Zacks Investment Research 2023 Apr 26
NVRO Stock News Image - Zacks Investment Research

The average of price targets set by Wall Street analysts indicates a potential upside of 53.7% in Nevro (NVRO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Investment Research 2023 Apr 25
NVRO Stock News Image - The Motley Fool

Today Nevro announced the appointment of a new CEO/president along with its preliminary 2023 Q1 financial results. With a possible recession looming, investors are exiting the cash-flow-negative medtech today.

The Motley Fool 2023 Apr 20
10 of 50